Compound Report Overview
Compound Identifier:
703155
Development Status:
Clinical Phase IIIII
SMILES:
CC(O)NC1C(O)C(OC2OC(CO)C(OC3OC(C(OC4OC(CO)C(OC5OC(CO)C(O)C(OC(O)C)C5O)C(OC(O)C)C4O)C(OC(O)C)C3O)C(O)O)C(OC(O)C)C2O)C(CO)OC1OC6C(CO)OC(OC7C(CO)OC(OC8C(CO)OC(O)C(O)C8OC(O)C)C(O)C7OC(O)C)C(O)C6OC(O)C